CNI(CNI)
CNI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $19.07B | $19.85B | $20.98B | $22.28B | $23.15B |
| Low | $18.79B | $19.50B | $20.54B | $21.81B | $22.66B |
| High | $19.46B | $20.60B | $21.51B | $22.85B | $23.74B |
| EBITDA Avg | $10.25B | $10.68B | $11.28B | $11.98B | $12.45B |
| Low | $10.10B | $10.49B | $11.04B | $11.73B | $12.19B |
| High | $10.47B | $11.08B | $11.57B | $12.29B | $12.77B |
| EBIT Avg | $8.18B | $8.52B | $9.01B | $9.56B | $9.94B |
| Low | $8.07B | $8.37B | $8.82B | $9.36B | $9.73B |
| High | $8.35B | $8.84B | $9.24B | $9.81B | $10.19B |
| Net Income Avg | $5.23B | $5.78B | $6.40B | $7.02B | $7.19B |
| Low | $5.17B | $5.65B | $6.23B | $6.82B | $6.99B |
| High | $5.30B | $5.96B | $6.61B | $7.25B | $7.43B |
| EPS Avg | $8.39 | $9.26 | $10.27 | $11.25 | $11.53 |
| Low | $8.28 | $9.06 | $9.98 | $10.94 | $11.21 |
| High | $8.50 | $9.55 | $10.60 | $11.62 | $11.91 |
| Analysts (Rev / EPS) | 17 / 19 | 17 / 19 | 8 / 9 | 13 / 8 | 8 / 14 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.73B | $4.92B | $4.81B | $5.03B | $4.84B | $5.10B | $5.08B | $5.31B |
| Low | $4.62B | $4.81B | $4.68B | $4.90B | $4.71B | $4.97B | $4.95B | $5.17B |
| High | $4.88B | $5.04B | $4.95B | $5.18B | $4.99B | $5.25B | $5.23B | $5.47B |
| EBITDA Avg | $2.54B | $2.65B | $2.58B | $2.70B | $2.60B | $2.74B | $2.73B | $2.86B |
| Low | $2.48B | $2.58B | $2.52B | $2.64B | $2.53B | $2.67B | $2.66B | $2.78B |
| High | $2.62B | $2.71B | $2.66B | $2.79B | $2.68B | $2.82B | $2.81B | $2.94B |
| EBIT Avg | $2.03B | $2.11B | $2.06B | $2.16B | $2.08B | $2.19B | $2.18B | $2.28B |
| Low | $1.98B | $2.06B | $2.01B | $2.10B | $2.02B | $2.13B | $2.12B | $2.22B |
| High | $2.09B | $2.16B | $2.13B | $2.22B | $2.14B | $2.26B | $2.25B | $2.35B |
| Net Income Avg | $1.31B | $1.36B | $1.24B | $1.46B | $1.43B | $1.48B | $1.34B | $1.64B |
| Low | $1.26B | $1.32B | $1.20B | $1.41B | $1.38B | $1.43B | $1.30B | $1.58B |
| High | $1.36B | $1.44B | $1.29B | $1.51B | $1.48B | $1.54B | $1.40B | $1.70B |
| EPS Avg | $2.16 | $2.24 | $2.04 | $2.40 | $2.35 | $2.44 | $2.21 | $2.70 |
| Low | $2.07 | $2.17 | $1.97 | $2.32 | $2.27 | $2.36 | $2.14 | $2.61 |
| High | $2.23 | $2.37 | $2.12 | $2.49 | $2.44 | $2.54 | $2.30 | $2.80 |
| Analysts (Rev / EPS) | 14 / 17 | 14 / 16 | 9 / 8 | 7 / 7 | 7 / 7 | 13 / 12 | 12 / 9 | 6 / 8 |